From the Food and Drug Administration.
Nightingale
S L
SL
Office of Health Affairs, Rockville, MD 20857, USA.
D000329:Advertising / Q000331:legislation & jurisprudence / Q000592:standards*; D000998:Antiviral Agents / Q000627:therapeutic use*; D000077404:Cidofovir; D003132:Commerce / Q000331:legislation & jurisprudence*; D003254:Consumer Advocacy; D017726:Cytomegalovirus Retinitis / Q000188:drug therapy; D003596:Cytosine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004345:Drug Industry / Q000331:legislation & jurisprudence / Q000592:standards*; D015507:Drugs, Investigational / Q000627:therapeutic use*; D006801:Humans; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000627:therapeutic use*; D010353:Patient Education as Topic; D017891:Pharmacoepidemiology / Q000331:legislation & jurisprudence / Q000592:standards*; D010947:Plants, Toxic; D014026:Nicotiana; D014481:United States; D014486:United States Food and Drug Administration
D000998:Antiviral Agents; D015507:Drugs, Investigational; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D003596:Cytosine; D000077404:Cidofovir